Imipenem Production Cost Reports

The report provides a detailed analysis essential for establishing an Imipenem production plant. It encompasses all critical aspects necessary for Imipenem production, including the cost of Imipenem production, Imipenem plant cost, Imipenem production costs, and the overall Imipenem production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating an Imipenem production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Imipenem is a broad-spectrum beta-lactam antibiotic used to treat a variety of bacterial infections. It is widely utlised as an antibiotic medication in hospitals for managing infections caused by multidrug-resistant bacteria, particularly those that affect the lungs, blood, and urinary tract.

It is commonly prescribed for infections caused by both Gram-positive and Gram-negative bacteria, including certain strains of E. coli, Pseudomonas, and Staphylococcus. It also finds its application in combination with another drug, cilastatin, to prevent its breakdown in the kidneys and enhance its effectiveness. Its main application is in treating infections in critically ill patients, such as those in intensive care units (ICUs). It is often used as an important medication in managing polymicrobial infections.

The market for Imipenem is driven by its utilisation as a broad-spectrum antibiotic in the treatment of severe bacterial infections, which largely contributes to its demand in the medical and healthcare sectors. Its application as a medication for the treatment of respiratory tract infections, urinary tract infections, skin infections, and intra-abdominal infections further promotes its demand in the medical and pharmaceutical industries.

Its involvement in combination with cilastatin to prevent renal degradation also boosts its demand in critical care settings. Industrial Imipenem procurement is influenced by factors such as the cost of raw materials (e.g., thienamycin), regulatory compliance, and stringent quality control standards. Additionally, advancements in production technologies, supplier reliability, and distribution efficiency also drive the market for Imipenem. Sustainability practices and the growing focus on combating antibiotic resistance also play a crucial role in shaping the procurement processes globally.

Raw Material for Imipenem Production

According to the Imipenem production plant project report, the major raw materials for Imipenem production include Streptomyces cattleya- Methyl Formimidate.

Production Process of Imipenem

The extensive Imipenem production cost report consists of the following industrial production process:

1. Production from Streptomyces cattleya: The production process of Imipenem begins with the isolation of thienamycin from Streptomyces cattleya, which is a bacterium known for producing the natural precursor. Then, the thienamycin is reacted with methyl formimidate to introduce a methyl group at the nitrogen position. This reaction results in the formation of Imipenem as the final product. The product is purified through various techniques to ensure the final compound meets the required specifications for medical use.

Imipenem appears as a white to off-white crystalline powder and is odourless. The molecular formula of Imipenem is C12H17N3O4S, and its molecular mass is 299.35 g/mol. Its density is approximately 1.3 g/cm³. The compound is soluble in water and is administered intravenously or intramuscularly. The compound has a melting point of 178-179 degree Celsius, and it is not stable at high temperatures. Imipenem is usually combined with cilastatin to prevent its degradation by the enzyme dehydropeptidase I in the kidneys. It is sensitive to light and moisture and should be stored in a cool, dry place. It is generally safe when used as directed, but can cause side effects such as nausea, diarrhoea, and allergic reactions, including rash and anaphylaxis in some individuals. Its prolonged use may lead to antibiotic resistance or disruption of normal microbiota.